Call for Abstract

6th World Congress on Cell & Stem Cell Research, will be organized around the theme “Novel Therapies in Cell Science and Stem Cell Research”

Stem Cell Research-2016 is comprised of 20 tracks and 121 sessions designed to offer comprehensive sessions that address current issues in Stem Cell Research-2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Stem Cells: an undifferentiated cell of a multicellular organism which is capable of giving rise to indefinitely more cells of the same type, and from which certain other kinds of cell arise by differentiation.

  • Track 1-1Heart stem cells
  • Track 1-2Diabetes stem cells
  • Track 1-3Stem cell markers

Cord blood, which contains powerful stem cells, comes from a newborn's umbilical cord and is collected immediately after birth. Once the umbilical cord has been clamped and cut, the remaining blood in the umbilical cord is drawn into a collection bag

Cellular differentiation is the progression, whereas a cell changes from one cell type to another. Variation occurs numerous times during the development of a multicellular organism as it changes from a simple zygote to a complex system of tissues and cell types. Differentiation continues in adulthood as adult stem cells divide and create fully differentiated daughter cells during tissue repair and during normal cell turnover. Some differentiation occurs in response to antigen exposure. Differentiation dramatically changes a cell's size, shape, membrane potential, metabolic activity, and responsiveness to signals. These changes are largely due to highly controlled modifications in gene expression and are the study of epigenetics. With a few exceptions, cellular differentiation almost never involves a change in the DNA sequence itself. Thus, different cells can have very different physical characteristics despite having the same genome.

  • Track 3-1Protection of human stem cells
  • Track 3-2Stem cell and insulin
  • Track 3-3Embryonic stem cell research
  • Track 3-4Hematopoietic malignancies
  • Track 3-5Immune cells regulate blood stem cells

Somatic cell therapy is the administration to humans of autologous, allogeneic, or xenogeneic living cells which have been manipulated or processed ex vivo. Manufacture of products for somatic cell therapy involves the ex vivo propagation, expansion, selection. Somatic cell therapy is viewed as a more conservative, safer approach because it affects only the targeted cells in the patient, and is not passed on to future generations. Somatic gene therapy represents mainstream basic and clinical research, in which therapeutic DNA (either integrated in the genome or as an external episome or plasmid) is used to treat disease. Most focus on severe genetic disorders, including immunodeficiencies, haemophilia, thalassaemia and cystic fibrosis. Such single gene disorders are good candidates for somatic cell therapy.

  • Track 4-1Stem cell technology
  • Track 4-2Malignant and non-malignant diseases
  • Track 4-3Allogeneic bone marrow transplantation
  • Track 4-4Neuronal stem cells
  • Track 4-5Bone marrow transplants (leukemia) and antileukemia drugs
  • Track 4-6Stem cell educator and diabetes
  • Track 4-7Oral stem cell therapy
  • Track 4-8Induced pluripotent stem cells
  • Track 4-9Fetal stem cell therapy

 An abnormal mass of tissue, tumors are a classic sign of inflammation, and can be benign or malignant.  Tomour usually reflect the kind of tissue they arise in. Treatment is also specific to the location and type of the tumor. Benign tumors can sometimes simply be ignored, cancerous tumors; options include chemotherapy, radiation, and surgery.

  • Track 5-1Cancer cell biology, diagnostic and prognostic cancer biomarkers
  • Track 5-2Cancer stem cells and metastatic growth
  • Track 5-3Cancer therapy and clinical cancer research
  • Track 5-4Carcinogenesis and mutagenesis
  • Track 5-5Tumorogenesis and tumor growth

Metabolism is the set of life-nourishing chemical transformations within the cells of living organisms. These enzyme-catalyzed reactions allow organisms to grow and reproduce, maintain their structures, and respond to their environments. Metabolism is divided into two categories: catabolism, the breaking down of organic matter by way of cellular respiration, and anabolism, the building up of components of cells such as proteins and nucleic acids. 

  • Track 6-1Cell origins and cellular metabolism
  • Track 6-2Cell energy and cell functions
  • Track 6-3Molecular cell growth & proliferation
  • Track 6-4Cell motility, the cytoskeleton and muscle physiology
  • Track 6-5Cell signaling and receptors

The most well-established and widely used stem cell treatment is the transplantation of blood stem cells to treat diseases and conditions of the blood and immune system, or to restore the blood system after treatments for specific cancers. Since the 1970s, skin stem cells have been used to grow skin grafts for patients with severe burns on very large areas of the body. Only a few clinical centers are able to carry out this treatment and it is usually reserved for patients with life-threatening burns. It is also not a perfect solution: the new skin has no hair follicles or sweat glands. Research aimed at improving the technique is ongoing.

  • Track 7-1Heart damage and hematopoiesis
  • Track 7-2Baldness, missing teeth and deafness
  • Track 7-3Blindness and vision impairment
  • Track 7-4Neural and behavioral birth defects
  • Track 7-5Diabetes and infertility
  • Track 7-6Orthopedics and wound healing

Self-renewal and proliferation of stem cell populations is controlled, in part, by induction of apoptosis. The number of stem cells is therefore a balance between those lost to differentiation / apoptosis and those gained through proliferation. Apoptosis of stem cells is believed to be a dynamic process which changes in response to environmental conditions.

  • Track 8-1Genomic analysis and molecular basis of cancer
  • Track 8-2Ubiquitination pathways for cancer therapy
  • Track 8-3Novel therapeutics
  • Track 8-4Translational studies for cancer stem cell-based therapies
  • Track 8-5Epigenetics and cancer stem cells
  • Track 8-6Specific cancer immunotherapy
  • Track 8-7Tissue aging
  • Track 8-8Inflammatory diseases and cancer

Molecular biomarkers serve as valuable tools to classify and isolate embryonic stem cells (ESCs) and to monitor their differentiation state by antibody-based techniques. ESCs can give rise to any adult cell type and thus offer enormous potential for regenerative medicine and drug discovery. A number of biomarkers, such as certain cell surface antigens, are used to assign pluripotent ESCs; however, accumulating evidence suggests that ESCs are heterogeneous in morphology, phenotype and function, thereby classified into subpopulations characterized by multiple sets of molecular biomarkers.

  • Track 9-1Cancer Diagnostics and Biomarkers
  • Track 9-2Organ Cancer: Breast, Oral, Head and Neck Cancer
  • Track 9-3Myeloid, Lymphoid Leukemia’s
  • Track 9-4Cervical and Lung Cancer
  • Track 9-5Cancer Therapeutics
  • Track 9-6Ethical Issues in Stem Cells and Cancer Research

Histology is the scientific study of biological tissues. It is the microscopic study of the structure of biological tissues using special staining techniques combined with light and electron microscopy. Histology is the study of the microscopic structures of cells and tissues of plants and animals. 

  • Track 10-1Histopathology
  • Track 10-2Immunohistochemistry
  • Track 10-3Tissue antigens and antibodies
  • Track 10-4Basic cell staining technics

Epigenetics is the study of genetics, cellular and physiological phenotypic trait variations that are caused by external or environmental factors that switch genes on and off and affect how cells read genes instead of being caused by changes in the DNA sequence. Epigenetic change in eukaryotic biology is the process of cellular differentiation. During morphogenesis, totipotent stem cells become the various pluripotent cell lines of the embryo, which in turn become fully differentiated cells.

  • Track 11-1Gene expression and epigenomics
  • Track 11-2Genes silencing
  • Track 11-3Cancer epigenetics
  • Track 11-4 Cancer cells and genetic mutations
  • Track 11-5Cell based immunotherapy
  • Track 11-6stem cell therapy for infectious diseases
  • Track 11-7Cell based immunosuppression in transplantation
  • Track 11-8Epigenetics of the antibody response
  • Track 11-9Epigenetic DNA repair and cancer

Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. Gene therapy could be a way to fix a genetic problem at its source. The polymers are either expressed as proteins, interfere with protein expression, or possibly correct genetic mutations. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

  • Track 12-1Cell and gene therapy- potential applications
  • Track 12-2Stem cell and cellular therapies
  • Track 12-3Cell therapy: clinical trials
  • Track 12-4Advanced gene therapeutics
  • Track 12-5Advanced gene therapeutics
  • Track 12-6Clinical trials and research in cell and gene therapies
  • Track 12-7Regulatory and ethical issues of therapies
  • Track 12-8Human malignancies and potential therapy for cancer

Tissue Engineering is the study of the growth of new connective tissues, or organs, from cells and a collagenous scaffold to produce a fully functional organ for implantation back into the donor host. Powerful developments in the multidisciplinary field of tissue engineering have produced a novel set of tissue replacement parts and implementation approaches. 

  • Track 13-1Repair and regeneration to renal disease
  • Track 13-2Regenerative therapies
  • Track 13-3Regeneration of tissues and organs
  • Track 13-4Transplantation and graft rejection
  • Track 13-5Biomedical engineering
  • Track 13-6Graft vs host disease and crohn’s disease
  • Track 13-7Regeneration technologies for hearts, limbs and other organs

Computational Biology, sometimes referred to as bioinformatics, is the science of using biological data to develop algorithms and relations among various biological systems. Bioinformatics groups use computational methods to explore the molecular mechanisms underpinning stem cells. To accomplish this bioinformatics develop and apply advanced analysis techniques that make it possible to dissect complex collections of data from a wide range of technologies and sources.

The fields of stem cell biology and regenerative medicine research are fundamentally about understanding dynamic cellular processes such as development, reprogramming, repair, differentiation and the loss, acquisition or maintenance of pluripotency. In order to precisely decipher these processes at a molecular level, it is critical to identify and study key regulatory genes and transcriptional circuits. Modern high-throughput molecular profiling technologies provide a powerful approach to addressing these questions as they allow the profiling of tens of thousands of gene products in a single experiment. Whereas bioinformatics is used to interpret the information produced by such technologies. 

  • Track 14-1Bioinformatics analysis of stemcells
  • Track 14-2Biorobotics and biosensors
  • Track 14-3Cellular computing and drug discovery
  • Track 14-4Gene expression analysis

Somatic cell therapy is the administration to humans of autologous, allogeneic, or xenogeneic living cells which have been manipulated or processed ex vivo. Manufacture of products for somatic cell therapy involves the ex vivo propagation, expansion, selection. Somatic cell therapy is viewed as a more conservative, safer approach because it affects only the targeted cells in the patient, and is not passed on to future generations. Somatic gene therapy represents mainstream basic and clinical research, in which therapeutic DNA (either integrated in the genome or as an external episome or plasmid) is used to treat disease. Most focus on severe genetic disorders, including immunodeficiencies, haemophilia, thalassaemia and cystic fibrosis. Such single gene disorders are good candidates for somatic cell therapy.

  • Track 15-1Somatic cell nuclear transfer
  • Track 15-2Immune system rejection
  • Track 15-3Immune system rejection
  • Track 15-4Somatic human genetic engineering
  • Track 15-5Genetic modification of somatic stem cells
  • Track 15-6Insertional mutagenesis
  • Track 15-7Genotoxicity

Human embryogenesis is the process of cell division and cellular differentiation of the embryo that occurs during the early stages of development. Whereas human development entails growth from a stage celled zygote to an adult human being stage. Fertilization occurs when the sperm cell successfully enters and fuses with an egg cell (ovum). The genetic material of the sperm and egg then combine to form a single cell called a zygote and the germinal stage of prenatal development commences.

  • Track 16-1Molecular alterations during female reproductive aging
  • Track 16-2Role of sperm DNA integrity in fertility
  • Track 16-3Fertilization and infertility
  • Track 16-4Embryo Implantation
  • Track 16-5Role of macrophages in the placenta
  • Track 16-6Actors of human implantation

Aging process is the result of the inability of various types of stem cells to continue to replenish the tissues of an organism with functional differentiated cells capable of maintaining that tissues (or organ's) original function.

  • Track 17-1Age related disorders
  • Track 17-2Oxidative stress and cellular degeneration
  • Track 17-3Free radicals and antioxidants
  • Track 17-4Cellular aging and influence of diet
  • Track 17-5Reverses ageing process
  • Track 17-6Genomic damage and ageing

‘Stem Cell Research’ is an international forum to present and discuss current perspectives in cell and stem cell research. Stem Cell Research is the unified study of the properties of cells and living organisms and all aspects of their interactions. Stem Cell Research has the goal to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need.

  • Track 18-1Stem cell products and analysis
  • Track 18-2Stem cell innovations and research In USA
  • Track 18-3Different cellular classes and scope In Uk
  • Track 18-4Clinical trials in USA and Europe

Cellular differentiation is the progression, whereas a cell changes from one cell type to another. Variation occurs numerous times during the development of a multicellular organism as it changes from a simple zygote to a complex system of tissues and cell types. Differentiation continues in adulthood as adult stem cells divide and create fully differentiated daughter cells during tissue repair and during normal cell turnover. Some differentiation occurs in response to antigen exposure. 

  • Track 20-1Stem cell differentiation and bioengineering
  • Track 20-2Self-renewal and differentiation functions
  • Track 20-3Regeneration of brain stem cells
  • Track 20-4Neural stem cell proliferation
  • Track 20-5Immune cell response
  • Track 20-6Tumor cell development